Symbols

Aerovate Therapeutics Drops 1.47% Amid Impending Jade Biosciences Merger

Generated by AI AgentAinvest Movers Radar

Friday, Apr 25, 2025 6:42 pm ET1min read

Aerovate Therapeutics, Inc. (AVTE) shares fell 1.47% on Thursday, marking the fourth consecutive day of decline, with a total drop of 3.25% over the past four days.

The primary factor influencing the recent fluctuations in AerovateAVTE-- Therapeutics, Inc. (AVTE) stock price is the impending business combination with Jade BiosciencesJADE--, Inc. This merger is anticipated to be finalized on April 28, 2025. Furthermore, Aerovate Therapeutics stockholders have given their approval for the proposed merger with Jade Biosciences.

Ainvest Movers Radar

Knowing stock market today at a glance

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments

﻿

Add a public comment...

No comments yet

AInvest
PRO

Editorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process. While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context. Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue